Xxlofoten AS

Org. no. 987734841 · Vågan · Founded 2005 · 30 employees

Score · fiscal year 2025

48of 100

How to read this: the company is ahead of 45 % of companies in the Morning class Small in the same sector in 2025. What does this mean?

Rank in the Morning class Small: 142 of 258 · What are Morning company classes?
Place in the whole sector: 535 of 963 · Kultur og fritid

Profile

Cheetah · Sprinter

High profitability, lower solidity

Position against comparable companies in 2025, not a verdict on the company. Based on profitability 67 and solidity 39 out of 100 among companies in the Morning class Small in the same sector in 2025. Methodology

Against the sector

Xxlofoten AS is 2 points below the median for companies in the Morning class Small in the same sector in 2025.

Median score 50 among 258 companies.

Against companies in the Morning class Small in the same sector in 2025: operating margin 9.4% (median 5.8%) and equity ratio 19.5% (median 26.6%).

Source: Register of Company Accounts and Central Coordinating RegisterFetched 4 November 2026Report an issue
Key figures · 2025

The numbers behind the score

The numbers behind the score · 2025
MeasureCompanyMedianAhead of
Operating revenue41 MNOK20 MNOK
Operating margin 9.4% 5.8% 66 %
Profit margin 9.8% 4.5% shown, not part of the index
Return on assets 17.6% 9.9% 67 %
Equity ratio 19.5% 26.6% 44 %
Debt-to-equity 4.13 1.95 35 %
Current ratio 1.12 1.15 47 %
Revenue growth 2.3% 6.2% 33 %
Revenue per employee1.37 MNOK0.54 MNOK

The median and “ahead of” refer to companies in the Morning class Small in the same sector in 2025. The bar shows the share of companies the figure is ahead of.

With an index of 48, Xxlofoten AS does better than 45% of companies in the Morning class Small in the same sector (258 companies) in 2025.

Over time

Score 2023–2025

CompanyMedian0255075100202320242025
  • Xxlofoten AS
  • Median: companies in the Morning class Small in the same sector
Summary analysis

Xxlofoten AS has a score of 48 for 2025, rank 535 of 963 in the sector.

Strongest: Profitability: percentile 67 against peers, operating margin 9.4% against a median of 5.8%.

Weakest: Growth: percentile 33 against peers, revenue growth 2.3% against a median of 6.2%. Solidity: percentile 39 against peers, equity ratio 19.5% against a median of 26.6%.

Worth a closer look

Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made

Analysis · 2025

What the numbers say

Xxlofoten AS had an operating margin of 9.4% and an equity ratio of 19.5% in 2025, and ranks 535 of 963 in Kultur og fritid.

No large changes in the key figures from 2024 to 2025.

This text is generated automatically from the 2025 accounts.

Estimated value · 2025

Three simple methods

The methods give between 5 MNOK and 31 MNOK.

MethodInputMultipleEstimate
P/E Net profit: 3.1 MNOK 10.0 31 MNOK
EV/EBIT Operating profit: 3.9 MNOK
minus net debt 5.0 MNOK
8.0 26 MNOK
P/B Equity: 4.9 MNOK 1.0 5 MNOK

A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation

Indications · 2025

Worth a closer look

No rules were triggered for this year.

Indications based on the latest annual accounts from open data. Not investment or financial advice.

Financial costs were 1.9% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.

See interest rates, prices and exchange rates for the sector

Data quality

No anomalies found in the figures.

Stress test · 2026

Scenario analysis: the sector's weakest year

We have no accounts for 2026, the sector's weakest year, for this company.

The sector's weakest year was 2026, with a median operating margin of −5.4%. Based on the 7 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology

Components · 2025

What the score is made of

Profitability67 weight 30%
Solidity39 weight 25%
Liquidity47 weight 15%
Growth33 weight 15%
Consistency41 weight 15%

Durability: 56 (average over 3 years)

Index version 2. Data completeness 100%: the share of the weights that had data.

2025

Questions and answers

How profitable is Xxlofoten AS?

The operating margin was 9.4% in 2025, against a median of 5.8% among companies in the Morning class Small in the same sector. Return on assets was 17.6%.

How solid is Xxlofoten AS?

The equity ratio was 19.5% in 2025 (median 26.6%). Debt-to-equity was 4.13 (median 1.95).

What is the liquidity of Xxlofoten AS like?

The current ratio was 1.12 in 2025 (median 1.15).

How does Xxlofoten AS compare in Kultur og fritid?

Xxlofoten AS ranks 535 of 963 in Kultur og fritid for 2025. Among companies in the Morning class Small it is number 142 of 258. Revenue changed by 2.3% from the year before.

From the Central Coordinating Register

Org. no.
987734841
Legal form
AS
Sector
Kultur og fritid (93.291)
Morning company class
Small
Employees
30 registered 10 October 2026
Founded
12 January 2005 21 years in operation
Share capital
3.71 MNOK
Business address
Johan E. Paulsens gate 9, 8300 SVOLVÆR (VÅGAN)
Municipality
Vågan rank 6–16 of 18 in KOSTRA group 2
Latest accounts filed
2025

Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre

Ownership and roles

Loading roles …

Source: Central Coordinating Register, fetched 31 October 2026. Only names are shown.

Owners and shareholdings will appear here once the shareholder data extract is in place.

Coming · not built yet

Error in the data?

Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.

Report an issue

Figures last fetched 4 November 2026.

Details

Year by year · 2023–2025

Key figure202320242025Trend
Index635748
Rank264359535
Operating margin19.3%11.1%9.4%
Return on assets26.0%18.3%17.6%
Equity ratio30.7%19.3%19.5%
Current ratio1.421.151.12
Revenue growth–43.4%2.3%

Accounts

From the Brønnøysund Register Centre, in the company's reporting currency (NOK).

Key figure202320242025
Operating revenue27.9 MNOK40.0 MNOK41.0 MNOK
Operating profit5.4 MNOK4.5 MNOK3.9 MNOK
Profit before tax5.1 MNOK4.4 MNOK4.0 MNOK
Net profit4.0 MNOK3.5 MNOK3.1 MNOK
Financial expenses0.4 MNOK0.5 MNOK0.4 MNOK
Total assets21.2 MNOK26.7 MNOK24.9 MNOK
Current assets10.9 MNOK17.9 MNOK16.4 MNOK
Equity6.5 MNOK5.2 MNOK4.9 MNOK
Retained earnings–0.0 MNOK0.0 MNOK
Total liabilities14.7 MNOK21.6 MNOK20.1 MNOK
Current liabilities7.7 MNOK15.5 MNOK14.6 MNOK

Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 4 November 2026, accounts id 7009170.